Gene · 5627
Papers1,864
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,864
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An exploratory study on the publication stages of early access articles in different bibliographic databases: A case study of IEEE journals. | PLoS One | 2025 | 40498725 | PubTator, text mining | PubMed |
| Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism. | J Thromb Haemost | 2025 | 40436275 | PubTator, text mining | PubMed |
| PROS1-MERTK Axis Drives Tumor Microenvironment Crosstalk and Progression in Papillary Thyroid Microcarcinoma. | Adv Sci (Weinh) | 2025 | 40433916 | PubTator, text mining | PubMed |
| Diagnosing protein S deficiency - Navigating challenges. | Clin Biochem | 2025 | 40419135 | PubTator, text mining | PubMed |
| Editorial: Case reports in thrombosis: 2024. | Front Cardiovasc Med | 2025 | 40376145 | PubTator, text mining | PubMed |
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing. | J Thromb Haemost | 2025 | 40286913 | PubTator, text mining | PubMed |
| Novel Association of Thrombophilic PROS1, PROC and CPB2 Genes Polymorphisms with Recurrent Spontaneous Miscarriage Women in Jordan. | Clin Appl Thromb Hemost | 2025 | 40232193 | PubTator, text mining | PubMed |
| In silico research of coagulation- and fibrinolysis-related genes for predicting prognosis of clear cell renal cell carcinoma. | Transl Androl Urol | 2025 | 40114841 | PubTator, text mining | PubMed |
| Population-Scale Studies of Protein S Abnormalities and Thrombosis. | JAMA | 2025 | 40029645 | PubTator, text mining | PubMed |
| Structural and Functional Insights into GGCX-FIX Interaction: Implications for Vitamin K-Dependent Bleeding Disorders. | bioRxiv | 2025 | 40027771 | PubTator, text mining | PubMed |
| PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy. | Cancer Immunol Res | 2025 | 39937118 | PubTator, text mining | PubMed |
| Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway. | Sci Rep | 2025 | 39922934 | PubTator, text mining | PubMed |
| Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies. | Blood Coagul Fibrinolysis | 2025 | 39918901 | PubTator, text mining | PubMed |
| New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis. | J Pharmacol Exp Ther | 2025 | 39892997 | PubTator, text mining | PubMed |
| Distinct TYRO3 and PROS1 expression levels contribute to preeclampsia pathogenesis. | Histochem Cell Biol | 2025 | 39878883 | PubTator, text mining | PubMed |
| A new hereditary PROS1 gene mutation caused isolated cortical venous thrombosis. | Thromb Res | 2025 | 39798525 | PubTator, text mining | PubMed |
| In Situ Proefferocytosis Microspheres as Macrophage Polarity Converters Accelerate Osteoarthritis Treatment. | Small | 2025 | 39780612 | PubTator, text mining | PubMed |
| Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening. | J Thromb Haemost | 2025 | 39675565 | PubTator, text mining | PubMed |
| Loss of protein C vs protein S results in discrepant thrombotic phenotypes. | Blood Adv | 2025 | 39657127 | PubTator, text mining | PubMed |
| A Computational Approach to Characterize the Protein S-Mer Tyrosine Kinase (PROS1-MERTK) Protein-Protein Interaction Dynamics. | Cell Biochem Biophys | 2025 | 39535659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5627/papers?page=5